Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer

SIMPLE SUMMARY: Despite the improvement in the treatment options for prostate cancer patients, we still lack effective treatments when the cancer has spread outside the prostate. Therefore, there is an urgent need to develop new therapies that will work better in this setting. Our study has identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, R. William, Azam, Haleema, Aura, Claudia, Russell, Niamh, McCormack, Janet, Corey, Eva, Morrissey, Colm, Crown, John, Gallagher, William M, Prencipe, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760758/
https://www.ncbi.nlm.nih.gov/pubmed/33260953
http://dx.doi.org/10.3390/cancers12123540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760758/
https://www.ncbi.nlm.nih.gov/pubmed/33260953
http://dx.doi.org/10.3390/cancers12123540

Ejemplares similares